Levetiracetam with standard chemo-radiation for hypoxic glioblastoma
Treatments studied
Part of Cancer clinical trials.
This trial tests whether adding an extended-release seizure medication (levetiracetam) to the standard treatment plan (surgery followed by radiation and chemotherapy) can improve outcomes for people with a specific type of brain tumor called glioblastoma, especially when the tumor shows signs of low oxygen levels (hypoxia).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 69 years old.
- You have been diagnosed with a type of brain tumor called glioblastoma (IDH-wildtype).
- Your tumor shows signs of low oxygen levels (confirmed by a special test).
- You are scheduled to receive the standard treatment (surgery, then radiation and chemotherapy with temozolomide).
- You are generally healthy, with adequate blood counts, liver, and kidney function.
- You have never had brain cancer treatment before or taken seizure medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding the study drug azeliragon to standard radiation and chemotherapy can help people with newly diagnosed glioblastoma. The study will also look at how the tumor responds to the added drug.
This trial tests a new drug combination for people with newly diagnosed glioblastoma, a type of brain cancer. It adds an immunotherapy drug (adebrelimab) to standard chemotherapy, and some participants also receive hyperbaric oxygen therapy, which may help the treatment work better.
This trial tests a combination of two drugs—vebreltinib and temozolomide—for people with a type of brain cancer called glioblastoma. It is for those who have already had surgery to remove as much of the tumor as possible.
This trial tests whether adding a special type of radiofrequency electromagnetic field treatment to standard chemotherapy and radiation therapy helps people with newly diagnosed glioblastoma. It is for patients who are planning to receive standard treatment and have had surgery to remove the tumor.
This trial tests a more intense chemotherapy plan for people with glioblastoma who had only partial removal of their tumor or whose tumor grew back quickly. The goal is to see if this approach can improve outcomes.
This early-phase study tests whether liposomal curcumin, added to standard radiation plus temozolomide, can improve treatment outcomes in newly diagnosed high-grade gliomas. It focuses on safety and how well the treatment can be given with the usual therapy plan.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.